As of 2024-12-12, the Relative Valuation of Bioventus Inc (BVS) is (8.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.58 USD, the upside of Bioventus Inc based on Relative Valuation is -177.4%.
The range of the Relative Valuation is (8.15) - (7.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 24.4x | 20.6x |
| Forward P/E multiples | 16.2x - 16.3x | 16.2x |
| Fair Price | (8.15) - (7.92) | (8.96) |
| Upside | -170.4% - -168.4% | -177.4% |
| Date | P/E |
| 2024-12-11 | -23.69 |
| 2024-12-10 | -23.47 |
| 2024-12-09 | -22.81 |
| 2024-12-06 | -24.01 |
| 2024-12-05 | -23.92 |
| 2024-12-04 | -22.69 |
| 2024-12-03 | -24.29 |
| 2024-12-02 | -25.24 |
| 2024-11-29 | -25.26 |
| 2024-11-27 | -25.26 |
| 2024-11-26 | -25.22 |
| 2024-11-25 | -23.64 |
| 2024-11-22 | -24.07 |
| 2024-11-21 | -23.66 |
| 2024-11-20 | -23.45 |
| 2024-11-19 | -23.82 |
| 2024-11-18 | -23.12 |
| 2024-11-15 | -23.10 |
| 2024-11-14 | -22.88 |
| 2024-11-13 | -22.94 |
| 2024-11-12 | -24.34 |
| 2024-11-11 | -25.57 |
| 2024-11-08 | -24.29 |
| 2024-11-07 | -23.10 |
| 2024-11-06 | -23.18 |
| 2024-11-05 | -23.60 |
| 2024-11-04 | -28.18 |
| 2024-11-01 | -27.91 |
| 2024-10-31 | -27.89 |
| 2024-10-30 | -27.91 |
| 2024-10-29 | -27.36 |
| 2024-10-28 | -26.84 |
| 2024-10-25 | -27.15 |
| 2024-10-24 | -27.44 |
| 2024-10-23 | -27.32 |
| 2024-10-22 | -26.66 |
| 2024-10-21 | -26.19 |
| 2024-10-18 | -26.62 |
| 2024-10-17 | -25.79 |
| 2024-10-16 | -26.56 |
| 2024-10-15 | -26.16 |
| 2024-10-14 | -25.84 |
| 2024-10-11 | -24.93 |
| 2024-10-10 | -23.12 |
| 2024-10-09 | -23.58 |
| 2024-10-08 | -23.82 |
| 2024-10-07 | -23.00 |
| 2024-10-04 | -24.15 |
| 2024-10-03 | -23.99 |
| 2024-10-02 | -24.21 |